Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 10:31 AM ET

Date/Time Source News Release
05/30/2025 08:00 AM EDT GlobeNewswire Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
05/27/2025 08:30 AM EDT GlobeNewswire Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
05/12/2025 04:15 PM EDT GlobeNewswire Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
05/05/2025 04:01 PM EDT GlobeNewswire Coherus to Report First Quarter 2025 Financial Results on May 12, 2025
05/01/2025 05:04 PM EDT GlobeNewswire Coherus to Participate in Upcoming Investor Conferences
04/28/2025 10:10 AM EDT GlobeNewswire Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025
04/14/2025 08:00 AM EDT GlobeNewswire Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
04/01/2025 08:00 AM EDT GlobeNewswire Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes
03/25/2025 04:30 PM EDT GlobeNewswire Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual Meeting
03/10/2025 04:12 PM EDT GlobeNewswire Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update
Page

Additional News

As of June 3, 2025 • 10:31 AM ET

Date/Time Source News Release
05/12/2025 10:47 PM EDT SeekingAlpha Coherus outlines $150M-$200M LOQTORZI NPC target while advancing pipeline through partnerships
05/12/2025 10:46 PM EDT SeekingAlpha Coherus BioSciences, Inc. (CHRS) Q1 2025 Earnings Call Transcript
05/12/2025 05:30 PM EDT Zacks Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates
05/12/2025 04:33 PM EDT SeekingAlpha Coherus BioSciences Non-GAAP EPS of -$0.35, revenue of $7.6M
05/12/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - Coherus BioSciences Inc.
05/11/2025 06:48 PM EDT KlickAnalytics CHRS - Historical Price Movements Surrounding Earnings
05/11/2025 06:43 PM EDT KlickAnalytics CHRS - Historical Earnings Price Analysis
04/17/2025 05:53 AM EDT SeekingAlpha Coherus BioSciences: Cleaning The Balance Sheet And Developing New Drugs
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.